Exchange: NASDAQ·Updated 06:37 PM EDT
NPCE logo

NPCE NeuroPace Inc

$14.30
$0.13
(0.92%)
Today
Closed $14.28
$0.02
(0.14%)
After Hours
EarningsNov 3
Mkt Cap$490.15M
Vol235,655.00

About NPCE

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
41

Bearish Sentiment

How do you feel about NPCE?

Advertisement|Remove ads.